The little blue pill that has transformed the lives of many men may be beneficial for some women on antidepressants who experience sexual dysfunction, a small trial has shown.

Also known as sildenafil, the drug is often prescribed to help men's erectile dysfunction, but an eight-week study shows it helps women who experience sexual problems from antidepressant use

Contrary to the popular belief, authors of a new study now suggest that antidepressant drugs do more good than harm to children and teenagers. There have been many instances when parents blamed antidepressants for the suicides of their depressed children and many studies showed that drugs might promote suicidal thoughts.

It prompted the Food and Drug Administration to send out a warning to doctors and also in 2004, the FDA called for "black box" warning labels on antidepressants. However, many experts believe that after the warning to curb the use of antidepressants, there was a sudden surge in U.S. youth suicides that was blamed on reluctance to try antidepressants

The Food and Drug Administration approves the first generic version of Effexor (venlafaxine), for the treatment of major depressive disorder (MDD).

Gary J. Buehler, Director, Office of Generic Drugs, says in a statement, "This approval is another example of our agency's efforts to increase access to safe and effective generic alternatives as soon as the law permits."

He adds, "Venlafaxine is a widely used antidepressant, and its generic version can bring significant savings to the millions of Americans diagnosed with MDD

A new study finds that mild sadness may trigger a major depressive episode. However, relapse is more likely in patients who are taking antidepressants than those who underwent cognitive behavioral therapy (CBT).

University of Toronto researcher Zindel V. Segal and his colleagues say that people who have recovered from major depression are more at risk for relapse

Zocor, a cholesterol-cutting drug from Merck and Zoloft, antidepressant from Pfizer are going off patent this month. Merck's patent for Zocor expires Friday while Zoloft loses patent protection on June 30.

According to a report by CNN Money, Zocor had $4.4 billion and Zoloft totaled $3.3 billion in 2005 sales